ThermoDox To Enter Early Access Program in Europe for Patients with Recurrent Chest Wall Breast Cancer
News
Celsion Corporation has announced it signed an agreement with myTomorrows to implement an Early Access Program for ThermoDox in European Union countries along with Switzerland, to be used in the ... Read more